patient
sampl
retrospect
identifi
cohort
hct
recipi
experienc
episod
respiratori
virusassoci
pneumonia
within
year
hct
four
patient
distinct
episod
pneumonia
caus
differ
virus
separ
month
patient
underw
hct
fred
hutchinson
cancer
research
center
provid
written
inform
consent
allow
use
store
specimen
medic
record
studi
approv
center
institut
review
board
patient
elig
analysi
radiograph
clinic
evid
lower
respiratori
tract
diseas
confirm
respiratori
viru
detect
bal
bal
sampl
obtain
adult
year
old
wash
ml
steril
isoton
salin
via
bronchoscopi
smaller
volum
use
children
pneumonia
virolog
confirm
test
bal
sampl
direct
fluoresc
antibodi
cultur
shell
vial
qualit
reversetranscript
pcr
rtpcr
rsv
piv
type
influenza
ab
virus
rhinovirus
pcr
adenovirus
qualit
rtpcr
alon
mpv
nonsever
acut
respiratori
syndrom
human
cov
multiplex
qualit
pcr
panel
avail
test
clinic
sampl
center
sinc
may
bal
sampl
also
submit
routin
bacteri
fungal
acidfast
bacilli
cultur
detect
cmv
herp
simplex
viru
patient
serum
andor
plasma
sampl
prospect
collect
weekli
laboratori
monitor
first
day
vari
interv
year
hct
although
serum
plasma
sampl
test
refer
collect
serum
sampl
throughout
articl
bal
residu
serum
sampl
store
frozen
analysi
obtain
serum
sampl
correspond
close
date
bronchoscopi
includ
patient
either
store
bal
store
serum
sampl
concomit
store
bal
serum
sampl
avail
subset
patient
store
bal
sampl
previous
test
posit
rsv
piv
influenza
virusb
viru
mpv
cov
test
quantit
rtpcr
previous
detect
viru
store
serum
sampl
also
test
quantit
rtpcr
viru
previous
detect
bal
sampl
quantit
rtpcr
assay
total
nucleic
acid
isol
bal
specimen
quantit
rtpcr
assay
perform
use
specimen
reaction
quantit
assay
linear
viral
copiesreact
limit
detect
copiesreact
copiesml
differ
nucleic
acid
extract
method
qiaamp
viral
rna
mini
kit
qiagen
use
serum
enabl
process
larger
volum
provid
sensit
copiesml
cutoff
copiesreact
serum
sampl
test
quantit
rtpcr
use
primer
method
describ
bal
specimen
pcr
method
perform
accord
colleg
american
pathologist
standard
laboratori
pass
profici
test
viral
diagnost
statist
analysi
wilcoxon
ranksum
test
use
compar
quantit
viral
load
bal
sampl
among
patient
group
clinic
characterist
cox
proport
hazard
regress
use
analyz
overal
surviv
month
quantit
viral
load
first
bal
sampl
model
adjust
potenti
confound
includ
age
stem
cell
sourc
peripher
blood
stem
cell
vs
bone
marrow
cord
blood
presenc
lymphopenia
lymphocyt
day
collect
bal
fluid
mechan
ventil
within
day
bal
presenc
absenc
copathogen
copathogen
defin
pathogen
bacteria
fungi
opportunist
virus
bal
sampl
concomit
lung
biopsi
sampl
evalu
patient
repres
use
first
viral
load
avail
first
episod
pneumonia
characterist
patient
without
viral
rna
detect
serum
compar
use
wilcoxon
ranksum
test
nonparametr
continu
data
fisher
exact
test
categor
variabl
poisson
regress
robust
standard
error
estim
use
calcul
preval
rate
ratio
rr
clinic
outcom
among
hct
recipi
without
detect
viral
rna
model
adjust
stem
cell
sourc
presenc
lymphopenia
interv
hct
bal
sampl
age
donor
type
hlaident
sibl
vs
altern
donor
sex
condit
regimen
nonmyeloabl
vs
myeloabl
cmv
risk
group
donor
recipi
seroneg
vs
underli
diseas
risk
presenc
acut
grade
graftvshost
diseas
diagnosi
pneumonia
presenc
absenc
copathogen
year
transplant
also
consid
potenti
confound
confound
includ
multivari
model
alter
adjust
rr
outcom
interest
rsv
pneumonia
model
limit
confound
differ
consid
statist
signific
p
adjust
made
multipl
comparison
hct
recipi
store
bal
sampl
avail
test
figur
thirtyeight
patient
store
bal
sampl
without
serum
sampl
avail
patient
store
serum
sampl
without
bal
sampl
fortynin
patient
concomit
bal
concomit
serum
sampl
serum
sampl
collect
median
day
bal
sampl
interquartil
rang
day
day
bal
collect
studi
cohort
characterist
group
type
sampl
avail
shown
tabl
patient
lymphopenia
week
diagnosi
pneumonia
group
differ
respect
proport
pneumonia
episod
accompani
copathogen
patient
pulmonari
copathogen
type
aspergillu
common
infect
confirm
aspergillu
fumigatu
twelv
patient
cmv
pneumonia
coexist
bacteri
pathogen
includ
pseudomona
aeruginosa
patient
streptococcu
pneumonia
staphylococcu
aureu
coliform
acinetobact
nocardia
copathogen
includ
candida
speci
patient
mycobacterium
fortuitum
rhizopu
speci
quantit
respiratori
viru
detect
bal
fluid
five
bal
sampl
hct
recipi
previous
test
posit
neg
retest
rsv
sampl
influenza
viru
mpv
viral
rna
limit
detect
quantit
rtpcr
sampl
collect
sampl
previous
posit
cultur
rsv
sampl
direct
fluoresc
antibodi
influenza
viru
sampl
rsv
rtpcr
mpv
analyz
quantit
viral
load
associ
date
sampl
collect
found
correl
viral
load
time
within
studi
period
suggest
sampl
degrad
may
consist
contribut
lack
rna
amplif
pearson
coeffici
analys
perform
use
amplifi
bal
sampl
hct
recipi
three
patient
separ
episod
pneumonia
patient
bal
sampl
per
infect
use
bal
sampl
maximum
quantit
viral
load
respiratori
viru
per
episod
pneumonia
bal
sampl
median
respiratori
viru
copi
number
follow
rsv
copiesml
rang
piv
copiesml
rang
influenza
viru
copiesml
rang
mpv
copiesml
rang
cov
copiesml
rang
figur
quantit
respiratori
viru
detect
bal
sampl
clinic
outcom
patient
examin
associ
quantit
viral
load
bal
sampl
first
episod
pneumonia
rsv
piv
mpv
influenza
cov
presenc
lymphopenia
presenc
copathogen
need
mechan
ventil
exclud
patient
multipl
respiratori
virus
detect
bal
sampl
patient
first
posit
bal
sampl
avail
statist
signific
differ
median
quantit
viral
load
patient
without
lymphopenia
day
collect
bal
fluid
copathogen
trend
toward
higher
viral
load
patient
requir
mechan
ventil
figur
associ
quantit
viral
load
measur
first
bal
sampl
overal
surviv
month
data
shown
quantit
respiratori
viru
detect
serum
sampl
rtpcr
use
test
serum
sampl
obtain
hct
recipi
near
date
diagnost
bal
sampl
correspond
episod
pneumonia
rsv
piv
influenza
viru
mpv
coinfect
mpvinfluenza
viruscov
coinfect
tabl
fortynin
patient
concomit
bal
serum
sampl
respiratori
viral
rna
detect
serum
sampl
patient
rsv
pneumonia
influenza
b
patient
mpvinfluenza
viru
cov
coinfect
influenza
viru
mpv
rna
detect
median
serum
rna
valu
follow
rsv
copiesml
rang
influenza
b
viru
copiesml
mpv
influenza
viru
copiesml
posit
serum
sampl
collect
median
day
closest
concomit
posit
bal
sampl
rang
day
day
similar
time
neg
serum
sampl
median
day
bal
sampl
rang
day
day
figur
provid
quantit
viral
load
bal
sampl
correspond
neg
posit
serum
sampl
patient
rsv
rna
detect
serum
correspond
bal
sampl
maximum
viral
load
rna
copiesml
detect
one
patient
influenza
b
viru
rna
detect
serum
copiesml
bal
sampl
patient
mpv
influenza
viru
detect
serum
copiesml
respect
bal
sampl
viral
rna
detect
serum
sampl
patient
piv
pneumonia
even
among
patient
highest
bal
viral
load
associ
quantit
rsv
load
bal
sampl
detect
rsv
rna
serum
analyz
hct
recipi
rsv
pneumonia
quantit
viral
load
concurr
bal
serum
sampl
median
maximum
bal
rsv
load
higher
patient
rsv
rna
detect
serum
sampl
patient
rsv
rna
detect
vs
copiesml
detect
viral
rna
serum
clinic
outcom
patient
viral
rna
detect
serum
underw
allogen
bone
marrow
transplant
pneumonia
serum
rna
detect
first
day
hct
addit
characterist
list
tabl
serum
viral
rna
detect
patient
week
antivir
therapi
aerosol
ribavirin
rsv
patient
patient
oseltamivir
patient
posit
serum
sampl
collect
within
day
posit
bal
sampl
five
patient
die
within
week
posit
serum
bal
sampl
viral
pneumonia
regard
final
diagnosi
caus
death
autopsi
perform
patient
diffus
alveolar
damag
neg
viral
cultur
result
focal
bronchiol
obliteran
organ
pneumonia
also
report
patient
patient
viral
rna
detect
serum
bacteri
fungal
viral
copathogen
bal
fluid
characterist
tabl
similar
patient
without
viral
rna
detect
serum
data
shown
entir
popul
analyz
differ
subgroup
time
diagnos
pneumonia
hct
howev
subset
patient
rsv
pneumonia
hct
pneumonia
diagnos
sooner
transplant
patient
rsv
rna
detect
serum
without
rsv
rna
serum
median
interv
rang
vs
day
rang
first
episod
respiratori
virusassoci
pneumonia
detect
viral
rna
serum
assess
risk
factor
use
mechan
ventil
death
within
day
first
posit
bal
sampl
analysi
restrict
patient
underw
allogen
transplant
univari
analysi
patient
viral
rna
detect
serum
increas
risk
mechan
ventil
rr
death
rr
within
day
first
posit
bal
sampl
associ
death
persist
adjust
model
rr
tabl
present
first
descript
quantit
viral
load
bal
detect
viral
rna
serum
sampl
among
hct
recipi
respiratori
viru
pneumonia
found
high
viral
load
bal
sampl
viru
type
find
similar
anoth
studi
mpv
identifi
quantit
rtpcr
bal
bronchial
wash
sampl
predominantli
immunocompromis
patient
also
detect
viral
rna
serum
among
subset
hct
recipi
soon
transplant
respiratori
viru
pneumonia
caus
rsv
influenza
viru
mpv
among
patient
piv
cov
pneumonia
patient
viral
rna
detect
serum
sampl
increas
risk
death
suggest
rna
detect
may
correl
diseas
sever
poor
outcom
among
patient
rsv
rna
detect
serum
sampl
associ
earlier
diagnosi
transplant
detect
respiratori
viral
rna
serum
sampl
patient
may
indic
system
viral
dissemin
associ
poor
prognosi
access
specimen
evalu
presenc
replic
viru
extrapulmonari
site
pathogen
viral
dissemin
one
possibl
mechan
explain
find
altern
explan
includ
physic
releas
intact
viral
particl
circul
result
high
viral
load
respiratori
tract
lead
epitheli
cell
death
detect
viru
viral
rna
antigenpres
cell
includ
pulmonari
macrophag
dendrit
cell
gain
direct
access
bloodstream
sever
infect
may
detect
viral
rna
serum
typic
respiratori
viru
infect
among
hct
recipi
use
sensit
rtpcr
assay
enabl
us
detect
occurr
studi
necessari
investig
whether
patient
upper
respiratori
tract
infect
alon
diseas
progress
upper
lower
respiratori
tract
may
also
respiratori
viru
rna
detect
serum
sampl
implic
viral
rna
detect
serum
probabl
vari
differ
virus
studi
avian
influenza
viru
suggest
detect
viral
rna
serum
plasma
marker
diseas
sever
poor
outcom
inde
avian
influenza
viru
infect
virem
phase
may
contribut
greatli
pathogenesi
although
definit
evid
detect
replicationcompet
viru
find
detect
rna
serum
associ
increas
risk
death
among
patient
rsv
infect
high
level
rna
detect
concomit
bal
sampl
time
rna
detect
serum
sampl
suggest
amount
infect
viru
may
influenc
likelihood
serum
rna
detect
may
indic
detect
rna
spill
pulmonari
tissu
damag
howev
patient
influenza
viru
detect
serum
correspond
bal
viral
load
consider
lower
suggest
detect
true
virem
phase
clinic
complic
influenza
includ
myocard
encephalopathi
although
clear
whether
repres
direct
viral
invas
aberr
host
immun
respons
import
question
investig
rtpcr
test
serum
respiratori
virus
may
offer
adjunct
method
diagnosi
sever
viral
respiratori
pneumonia
may
import
implic
therapi
monitor
certain
patient
studi
need
determin
whether
virus
influenza
viru
rsv
true
virem
phase
associ
detect
viral
rna
serum
may
indic
aerosol
therapi
limit
hct
recipi
viral
pneumonia
treatment
system
antivir
may
benefici
patient
major
strength
studi
provid
first
quantit
analysi
respiratori
viru
rna
bal
sampl
knowledg
largest
studi
conduct
date
evalu
respiratori
viral
load
bal
serum
sampl
hct
recipi
store
repositori
bal
serum
sampl
collect
prospect
studi
period
provid
valuabl
opportun
evalu
larg
quantiti
specimen
importantli
patient
receiv
standard
diagnost
workup
pneumonia
includ
bronchoscopi
first
clinic
radiograph
indic
lower
respiratori
diseas
although
detect
viral
rna
alon
ensur
replic
viru
present
nucleic
acid
detect
serum
associ
transmiss
andor
diseas
sever
rna
dna
virus
pcr
test
often
use
prompt
sensit
diagnosi
pneumonia
patient
possibl
lower
respiratori
tract
diseas
particularli
immunocompromis
popul
furthermor
mani
transplant
center
move
toward
molecularbas
laboratori
techniqu
diagnosi
respiratori
virus
pcr
test
serum
may
soon
wide
avail
infrequ
sampl
serum
may
even
underestim
frequenc
detect
circul
rna
frequent
regular
sampl
well
cellbas
assay
perform
time
pneumonia
may
increas
frequenc
detect
respiratori
viral
rna
other
report
respiratori
viral
rna
detect
whole
blood
peripher
blood
mononuclear
cell
sampl
serum
sampl
retrospect
natur
studi
limit
vari
collect
volum
bal
sampl
may
influenc
quantit
viral
result
although
would
expect
bal
dilut
factor
caus
major
differ
viral
load
previou
studi
quantit
test
nasal
wash
sampl
collect
volum
record
uncorrect
viral
load
compar
viral
load
correct
sampl
volum
differ
sampl
within
rang
assay
reproduc
viral
load
studi
assum
copi
viral
rna
equal
viru
particl
virus
studiedthat
detect
genom
rna
know
proport
viral
genom
infecti
genom
copi
specimen
infecti
vivo
quantifi
viral
rna
pcr
may
overestim
number
infecti
particl
addit
small
number
bal
sampl
test
neg
rtpcr
time
sampl
store
temperatur
optim
longterm
rna
storag
thu
surpris
degrad
may
occur
viral
rna
undetect
sampl
see
trend
decreas
quantit
viral
load
time
suggest
durat
storag
affect
rna
amplif
identifi
patient
viral
rna
detect
concomit
serum
sampl
abil
perform
rigor
multivari
analysi
outcom
limit
sampl
size
conclus
analysi
found
respiratori
virus
may
detect
high
viru
copi
number
bal
sampl
detect
viral
rna
serum
may
frequent
previous
appreci
among
hct
recipi
virolog
confirm
respiratori
viru
pneumonia
soon
transplant
studi
provid
evid
detect
respiratori
viru
rna
bloodstream
sever
immunocompromis
patient
may
associ
poor
outcom
circul
respiratori
viral
rna
may
provid
explan
viral
pathogenesi
especi
rsv
infect
rsv
rna
document
serum
sampl
patient
larger
studi
need
valid
find
determin
whether
detect
respiratori
viru
rna
serum
associ
diseas
sever
hct
recipi
sever
immunocompromis
popul
